Research
Hormonal
GLP-1 receptor agonists lower plasma glucose and suppress appetite, providing significant benefits for glycemic control and weight loss in type 2 diabetes and obesity.
If you have type 2 diabetes or obesity, GLP-1 receptor agonists are a proven, first-line treatment option that effectively lowers blood sugar and aids weight loss. Discuss these options with your healthcare provider to see if they are appropriate for your specific health profile.
StrongSupportsVERY_HIGH confidence
GLP-1 receptor agonists are now widely used in the treatment of type 2 diabetes and obesity, delivering significant benefits in glycemic control, weight loss, and cardiovascular protection.
Why this rating
The paper is a comprehensive review in Physiological Reviews citing widespread clinical use and significant benefits.
Source
Proglucagon-derived peptides: human physiology and therapeutic potential
Lærke S. Gasbjerg et al. · Physiological Reviews · 2025
DOI 10.1152/physrev.00057.2024
narrative_reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Glucagon regulates glucose and amino acid homeostasis and counters hypoglycemia.Strong
- GLP-2 analogs are effectively used in the management of short bowel syndrome, reducing the need for parenteral support and improving patient quality of life.Strong
- Glucagon remains essential for emergency hypoglycemia treatment.Strong
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →